Form D · Biotechnology

Palyon Medical Corp

New York, NY · CIK 0001463570

Offering snapshot reported Aug 10, 2009 · SEC filing

Reported sold
$24M
Offering amount: $24M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 27, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$12M$24MMay 8, 2009: $21,000,000.00May 8, 2009Aug 10, 2009: $24,000,000.00Aug 10, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$21,000,000 → $24,000,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 10, 2009Amendment$24,000,000$3,000,000vs May 8, 200911SEC filing
May 8, 2009Initial$21,000,000No comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$1.44M (estimated)
Finders' fees
$0
Form D file number
021-130784
$1,260,000 was paid and a warrant to purchase 3,726,708 shares of common stock was issued in connection with the initial sale, and the balance was paid in cash after the sale of the remaining securities.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Rockport Venture Securities, LLC113748Rockport Venture Securities, LLC · CRD 113748

Source: Form D, filed Aug 10, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gregory David Director, Executive
Glen Kashuba Director
Aidan King Director
Michael Liang Director
Daniel Omstead Director
Cherine Plumaker Executive
David Present Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
250 W. 57 Th Street, Suite 1716
New York, NY, 10107